District Court, District of Columbia December 23, 2004, CIV.A.04-1416(RBW) (Teva Pharmaceuticals, Industries, Ltd. v. Food & Drug Administration)

Also known as

United States · · · 23-12-2004

MEMORANDUM OPINION

WALTON, District Judge.

The plaintiffs filed this action to challenge a decision by the Food and Drug Administration (“FDA”), which permits the sale of brand generic drugs

1

during the generic exclusivity period provided for in 21 U.S.C. § 355(j)(5)(B)(iv)(I). Verified Amended Complaint (“Compl.”) ¶¶ 119-24.

2

The parties have filed cross-motions for summary judgment.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.